Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference

Rhea-AI Summary

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a leading platform for cell programming and biosecurity, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. The company's Chief Financial Officer, Mark Dmytruk, is scheduled to engage in a fireside chat on Friday, September 6 at 11:30 a.m. ET. This event presents an opportunity for investors and interested parties to gain insights into Ginkgo Bioworks' financial strategies and market position. The company has stated that additional details, including a webcast link and replay of the fireside chat, will be made available on their investor relations website at https://investors.ginkgobioworks.com/events.

Positive

• Participation in a major healthcare conference, potentially increasing visibility and investor interest
• Opportunity for the CFO to present the company's financial strategies and market position

Negative

• None.

BOSTON, Aug. 30, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Chief Financial Officer, Mark Dmytruk, is scheduled to participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Friday, September 6 at 11:30 a.m. ET.

Further details, a webcast link, and a replay of the fireside chat will be posted on the company's investor relations website at https://investors.ginkgobioworks.com/events.

About Ginkgo Bioworks

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats.  For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com

MEDIA CONTACT:

press@ginkgobioworks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-the-morgan-stanley-22nd-annual-global-healthcare-conference-302234549.html

SOURCE Ginkgo Bioworks

FAQ

When is Ginkgo Bioworks (DNA) participating in the Morgan Stanley Global Healthcare Conference?

Ginkgo Bioworks (DNA) is participating in the Morgan Stanley 22nd Annual Global Healthcare Conference on Friday, September 6, with a fireside chat scheduled for 11:30 a.m. ET.

Who will represent Ginkgo Bioworks (DNA) at the Morgan Stanley healthcare conference?

Mark Dmytruk, the Chief Financial Officer of Ginkgo Bioworks (DNA), will represent the company at the Morgan Stanley 22nd Annual Global Healthcare Conference.

Where can I find more information about Ginkgo Bioworks' (DNA) participation in the Morgan Stanley conference?

Further details, a webcast link, and a replay of the fireside chat will be posted on Ginkgo Bioworks' investor relations website at https://investors.ginkgobioworks.com/events.

What is the stock symbol for Ginkgo Bioworks mentioned in the press release?

The stock symbol for Ginkgo Bioworks mentioned in the press release is NYSE: DNA.